TY - JOUR
T1 - Balancing evidence and social responsibility when targeting clinical pharmacy services
T2 - the example of people with intellectual disabilities
AU - Bell, J Simon
AU - Kirkpatrick, Carl M
AU - Alderman, Christopher P
PY - 2015
Y1 - 2015
N2 - Evidence from systematic reviews and meta-analyses support the provision of pharmacy services to a range of patient groups. This includes patient groups with high burden conditions such as diabetes, asthma, hypertension and hyperlipidaemia. Evidence is an important factor that guides the development and delivery of new clinical pharmacy services. In the context of finite resources, targeting clinical pharmacy services to patient groups with demonstrated benefits is consistent with the principles of evidence-based decision making.
AB - Evidence from systematic reviews and meta-analyses support the provision of pharmacy services to a range of patient groups. This includes patient groups with high burden conditions such as diabetes, asthma, hypertension and hyperlipidaemia. Evidence is an important factor that guides the development and delivery of new clinical pharmacy services. In the context of finite resources, targeting clinical pharmacy services to patient groups with demonstrated benefits is consistent with the principles of evidence-based decision making.
UR - http://www.scopus.com/inward/record.url?scp=84937642600&partnerID=8YFLogxK
U2 - 10.1007/s11096-015-0117-0
DO - 10.1007/s11096-015-0117-0
M3 - Editorial
C2 - 25903939
AN - SCOPUS:84937642600
SN - 2210-7703
VL - 37
SP - 549
EP - 550
JO - International Journal of Clinical Pharmacy
JF - International Journal of Clinical Pharmacy
IS - 4
ER -